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Abstract
Female-to-male trans masculine adults who have sex with cisgender (non-transgender) males 
(TMSM) represent an understudied population in relation to HIV/STI risk. This study examined 
the role of syndemic conditions and social gender affirmation processes (living full-time in one’s 
identified gender) in potentiating sexual risk among TMSM adults in Massachusetts. Cross-
sectional data were restricted to TMSM who reported lifetime sexual behaviour with a cisgender 
male (n = 173; mean age = 29.4, SD = 9.6; 18.5% people of colour; 93.1% non-heterosexual 
identity; 56.1% hormones/surgery). Sexual risk outcomes were: lifetime STI diagnoses, three or 
more past-6-month sexual partners, and condomless anal/vaginal sex at last encounter with a 
cisgender male. Age- and survey mode-adjusted logistic regression models regressed sexual risk 
outcomes on the main effect of syndemics (six indicators summed: binge drinking, substance use, 
depression, anxiety, childhood abuse, intimate partner violence), followed by the interaction of 
syndemics and social gender affirmation. Syndemics were associated with increased odds of all 
sexual risk indicators (adjusted odds ratios (aORs) = 1.32–1.55; p < 0.0001). Social gender 
affirmation moderated the association between syndemics and condomless anal/vaginal sex at last 
encounter with a cisgender male (p < 0.0001). Syndemics were associated with sexual risk in 
TMSM who had socially affirmed their gender (aOR = 1.79; 95% CI = 1.42–2.25; p < 0.001), but 
not among those TMSM who had not (aOR = 0.86; 95% CI = 0.63–1.19; p = 0.37). Findings 
suggest that syndemic pathways to sexual risk are similar for TMSM who have socially gender 
affirmed as for cisgender MSM. Integration of syndemics and gender affirmation frameworks is 
recommended in interventions to address TMSM sexual risk.
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Introduction
The sexual health of female-to-male (FTM) trans masculine people – individuals assigned a 
female sex at birth who identify on the trans masculine spectrum (e.g. men, trans men, or 
other diverse gender identities and expressions) – remains understudied. Historically, 
research has assumed that trans masculine people have a heterosexual identity and therefore 
have an HIV and sexually transmitted infection (STI) behavioural risk profile similar to 
cisgender (non-transgender) females who have sex with cisgender females.1 However, more 
recent data suggest that heterogeneity of sexual identities, behaviours, and attractions is the 
norm, rather than the exception, in trans masculine people.2-9 According to the U.S. 
National Transgender Discrimination Survey, among trans masculine adults who reported 
their sexual orientation (n = 1314), 69.3% were non-heterosexually identified (13.5% gay; 
14.9% bisexual; and 40.9% queer).10 Trans masculine people who have sex with cisgender 
males (TMSM) represent a unique and understudied population, especially related to 
HIV/STI behavioural risk.3,5,10
Although HIV prevalence in TMSM ranges from 0 to 3% in the small convenience sample 
studies conducted to date,1,3-5,11-13 self-reported lifetime STI histories range from 6% to 
47%,3 and current HIV-related sexual risk behaviours from 7% to 69% depending on how 
risk was operationalised.3-5 A national study of TMSM (n = 45) found that only 31% 
reported “always” using a condom during vaginal sex, 40% reported using a condom 
“always” during anal sex, and 91% had a previous STI diagnosis.3 Another sample of 
TMSM in New England (n = 16) found that 43.8% had unprotected receptive vaginal sex 
with cisgender males of unknown HIV status in the past year, and 37.5% had a lifetime 
history of one or more STI.5 High prevalence of STIs and sexual risk behaviours with 
multiple concurrent partners may be a risk factor and augment HIV and STI rates, 
particularly in TMSM who partner with cisgender MSM – a group disproportionately 
affected by HIV.14
A syndemics framework has been used to understand the elevated prevalence of HIV and 
STIs among cisgender MSM in the USA.15-17 This framework posits that interacting, co-
occurring epidemics – such as mental health risks (e.g. depression and substance use) and 
victimisation (e.g., childhood sexual abuse and intimate partner violence) – synergistically 
increase HIV risk.18,19 Multiple studies document syndemic production of elevated HIV 
infection prevalence in MSM.15,16,20,21 Although a syndemic framework has been applied to 
trans masculine health risk for chronic disease (e.g. smoking, alcohol and weight 
depression),22 this conceptual framework has not to our knowledge been applied to TMSM 
sexual risk behaviour; the current study aims to fill this research gap.
In addition to syndemics which potentiate HIV/STI risk behaviours, gender affirmation may 
represent a social determinant of sexual health unique to TMSM. Gender affirmation has 
been defined as an interpersonal and shared process through which a person’s identity is 
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socially recognised.23 Gender affirmation is thus a dynamic process that can include social 
(e.g. name, pronoun and gender expression), medical (e.g. cross-sex hormones and surgery) 
and/or legal (e.g. legal name change and gender marker change) dimensions.24 Despite 
multiple dimensions of gender affirmation, this study conceptualises social transition (with 
or without medical and/or legal transition) as the critical gender affirmation component 
shaping sexual health behaviours and sexual risk indicators in TMSM. Social transition – 
living “full-time” in one’s identified gender – is a key identity juncture where being 
authentically seen or recognised (e.g. receiving identity validation by oneself and by others; 
being socially recognised as a man) becomes prioritised over and above other needs (e.g. 
sexual safety).
TMSM face many of the same social stressors that place cisgender MSM at-risk for HIV 
infection, including homophobia and stigma which ultimately fuel syndemics and predispose 
MSM to engage in high-risk sexual behaviours. However, qualitative data suggest that 
TMSM contend with added stigma and rejection from cisgender MSM due to being 
transgender men, including fear or anticipated rejection from cisgender males (e.g. 
internalised transphobia) for being transgender and not being socially affirmed or recognised 
for who they are.3 This fear may manifest behaviourally in TMSM-specific HIV-related 
risks linked to social gender affirmation.3 For example, one study noted TMSM’s 
vulnerability to a “gender role trigger” in which a male sex partner’s questioning of their 
gender role increases their risk for condomless sex as a means of demonstrating their 
masculinity or prioritising social affirmation of their gender ahead of sexual safety.5 
Similarily, TMSM in another study describe how their desire for sexual affirmation from 
their partners often superseded their desire to protect themselves from HIV and STIs.3 
Understanding whether and how social gender affirmation moderates the relationship 
between syndemic factors and sexual risk can inform culturally tailored HIV/STI prevention 
efforts for this community, including those reaching different subsets of TMSM most 
vulnerable and at highest risk of HIV and STIs.
Applying syndemic and gender affirmation frameworks, this paper sought to (1) examine the 
distribution and prevalence of sexual risk indicators in TMSM adults, including STI 
diagnoses, three or more sexual partners in the last six months, and condomless anal or 
vaginal sex at last encounter with a cisgender male; (2) test whether social gender transition 
moderated the relationship between syndemics and sexual risk behaviours (Figure 1), such 
that syndemics would be associated with sexual risk behaviour among TMSM who had 
socially transitioned, but that the same association would not be observed in TMSM who 
had not socially transitioned.
Methods
Participants and data analytic sample
Data were from a community-based convenience sample of 452 self-identified transgender 
and gender nonconforming adults from Massachusetts. Respondents were purposively 
recruited online and in-person from August to December 2013. Eligible respondents were 
age 18 years or older, self-identified as transgender or gender nonconforming, and lived in 
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Massachusetts for at least three months in the past year. Additional details on survey 
methodology can be found elsewhere.25
Gender identity was assessed using a two-step method,26 based on assigned sex at birth and 
current gender identity. For this analysis, data were restricted to trans masculine spectrum 
respondents who reported lifetime sexual behaviour with a cisgender male (n = 173).
Measures
Sexual risk outcomes—(1) A binary variable was created comparing participants 
reporting three or more sex partners in the past six months to individuals with 0–2 partners. 
(2) To assess lifetime STI diagnosis, participants were asked to respond to the following 
statement, “A doctor, nurse or other health professional has diagnosed me with a sexually 
transmitted disease other than HIV such as syphilis, chlamydia, gonorrhea, herpes, etc.” 
Participants who indicated that they had received an STI diagnosis were coded as yes for 
lifetime STI diagnosis (referent = no). (3) Condomless anal or vaginal sex with a cisgender 
male at last sexual encounter was created by coding participants reporting having anal and/or 
vaginal sex with a cisgender male and not using a condom during their last sexual encounter 
as yes (referent = no).
Independent variable—The syndemics variable was created by summing six variables to 
create a continuous variable ranging from 0 to 6 syndemic conditions. (1) Participants who 
reported drinking five or more alcoholic beverages over a few hours were coded as yes for 
binge drinking in the past six months (referent = no). The use of three or more drugs 
(marijuana, cocaine, crack, club drug, heroin, methamphetamine, poppers, hallucinogens, 
downers, painkillers, other drug) in the past 12 months was coded as yes for poly-drug use, 
otherwise it was coded as no. Depression and anxiety were each assessed by asking 
participants whether they had been diagnosed with the condition (yes/no). Participants 
reporting that they had been physically or sexually abused as a child (under 15 years old) 
were coded as yes for childhood abuse (referent = no). Intimate partner violence (IPV) was 
assessed by asking participants: “Have you ever been slapped, punched, kicked, beaten up, 
or otherwise physically or sexually hurt by your spouse (or former spouse), a boyfriend/
girlfriend, or some other intimate partner?” (yes/no).
Hypothesised moderator—Social gender affirmation was assessed with the following 
item, “Do you live full-time in your identified gender?” (yes/no). Social gender affirmation 
was selected as the hypothesised moderator because conceptually social transition represents 
the psychological desire that one’s felt or internal sense of gender be affirmed by both 
oneself and others, including sexual encounters, which may potentially influence sexual risk 
behaviours.
Sociodemographics
Age in years—Race and ethnicity were assessed separately and coded as White (non-
Hispanic) vs. people of colour (POC = Black, Latino, multiracial, other race/ethnicity). 
Survey mode was online vs. in-person. For education, participant responses were 
dichotomised as some college or less vs. college graduate or more. For employment, 
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participant responses were coded as employed (employed for wages, self-employed and/or 
an employed student), student only, unemployed, unable to work, and other. Participant’s 
self-reported income was coded as less than $20,000/year, $20,000 to $50,000/year, and 
$50,000 or more/year.
An indicator of binary/non-binary gender identity was created to compare respondents with 
non-binary gender identities (gender variant, genderqueer, androgynous, gender 
nonconforming) to those with binary gender identities (male, FTM, man). Medical gender 
transition was assessed with the following item, “Have you accessed any transgender-related 
medical interventions to affirm your gender (e.g. hormones, surgeries)?” (yes/no). Sexual 
orientation identity was assessed by asking, “How do you currently identify your sexual 
orientation?” Participant responses were coded as straight, gay/lesbian, bisexual, queer, other 
non-binary (questioning, I do not label my sexual orientation, unsure, asexual, other). For 
relationship, those who reported being in a relationship (i.e. partnered, civil union, married) 
were coded as being partnered and those not reporting being in a relationship were coded as 
not partnered (i.e. separated, divorced, widowed).
HIV testing history was coded as having been tested in the past six months, more than six 
months ago and never. HIV diagnosis lifetime was coded as having received an HIV 
diagnosis (yes) or not (no). Participants were also asked whether they had heard about pre-
exposure prophylaxis (PrEP) before (yes/no). Mental health treatment and utilisation was 
assessed by asking participants to report whether they were currently taking medicine or 
receiving treatment from a doctor or other health professional for any type of mental health 
condition or emotional problem (yes/no).
Data analysis
SAS® version 9.4 statistical software was used to analyse data. Data were multiply imputed 
using the fully conditional specification method (“chained equations”) due to differential 
missingness.27-31 Univariable descriptive statistics were obtained for all variables of interest. 
To empirically test whether syndemics were associated with sexual risk behaviour and 
whether there was an interaction effect by social gender affirmation, a series of adjusted 
logistic regression models were fit adjusting for age and survey mode. Specifically, three or 
more sexual partners (model 1a), STI diagnosis (model 1b), and unprotected anal or vaginal 
sex with a cisgender male (model 1c) were each independently regressed on syndemics to 
examine the main effects of syndemics on sexual risk behaviour. Next, the three sexual risk 
variables (models 2a–c) were each regressed on syndemics and social gender affirmation, 
and a multiplicative interaction term was added to examine whether effect modification by 
social gender affirmation (syndemic × social gender affirmation) was seen in the effects of 
syndemics on sexual risk behaviour.
Results
Table 1 descriptively presents sociodemographic characteristics by social transition. TMSM 
had a mean age of 29.4 (SD = 9.6); range 18–57 years. The majority (81.5%) were White 
(non-Hispanic), 18.5% were people of colour (POC): 7.5% Hispanic, 2.9% Black, 6.9% 
Multiracial, 1.2% Other Race. In terms of gender identity, 51.4% had a binary gender 
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identity (female-to-male, transgender man, man, or male) and 48.6% endorsed a non-binary 
gender identity (genderqueer, gender variant, or gender nonconforming). The vast majority 
of the sample (93.1%) identified as non-heterosexual (57.2% queer, 10.4% bisexual, 7.5% 
other label, 6.9% gay/same-gender attracted, 6.4% did not label their sexual orientation, 
2.3% questioning, 2.3% asexual). The majority (82.7%) had socially affirmed their gender, 
and 67.8% of those who had socially affirmed their gender had also medically affirmed their 
gender.
The prevalence of sexual behaviours and sexual risk indicators is presented in Table 2 
stratified by social gender affirmation. Overall, 5.8% reported a lifetime STI diagnosis, 
32.9% reported three or more sexual partners in the last six months, and 8.1% reported 
condomless anal or vaginal sex last time had sex with a cisgender male. Nearly 40% of 
participants had been tested for HIV in the past six months and the majority of TMSM had 
heard of PrEP (59.0%). The distribution of syndemic conditions is shown in Table 3. The 
mean number of syndemics (range 0–6) reported was 2.3 (SD = 1.5). The distribution of 
each syndemic factor by sexual risk outcome is presented in Table 4.
As shown in Table 5, models first tested main effects of syndemics on sexual risk. 
Syndemics were associated with an increased odds of all sexual risk indicators (aORs from 
1.32 to 1.55; p < 0.0001) (Table 5, Models 1–3A). Social gender affirmation was found to 
moderate the association between syndemics and condomless anal or vaginal sex at last 
encounter with a cisgender male (p < 0.0001) (Table 5). Specifically, syndemics were 
associated with sexual risk in TMSM who had socially affirmed their gender (aOR = 1.79; 
95% CI = 1.42, 2.25; p < 0.0001), but not among those TMSM who had not socially 
affirmed their gender (aOR = 0.86; 95% CI = 0.63, 1.19; p = 0.37) (Table 6).
Discussion
This study found that syndemic conditions are associated with sexual risk in TMSM – 
including having three or more sexual partners in the last six months, lifetime STI diagnosis 
and condomless anal and/or vaginal sex with a cisgender male in the last six months – 
corroborating previous research with cisgender MSM.15-17 Social gender affirmation was 
found to be associated with increased odds of lifetime STI diagnosis and three or more 
sexual partners in the past six months, but with decreased probability of condomless anal 
and/or vaginal sex with a cisgender male in the last six months. Indeed, TMSM who had not 
socially transitioned had a higher prevalence of condomless sex with a cisgender male 
partner at last sexual encounter than to those who had socially transitioned. This finding 
suggests that sexual health research and programming seeking to reach at-risk TMSM 
remain inclusive and promote diversity, not limit trans masculine samples to individuals who 
have affirmed their gender in any particular way. In this sample, TMSM who had not 
socially transitioned were younger age and more likely to report a genderqueer/gender 
variant/or gender nonconforming gender identity – these individuals were engaging in the 
highest current sexual risk behaviours.
In testing the hypothesis that syndemic dynamics are moderated by social gender affirmation 
in TMSM, syndemics were found to be associated with condomless vaginal and/or anal sex 
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among those TMSM who had socially affirmed their gender, but not in those who had not 
socially affirmed their gender. This finding suggests similar sexual risk patterns for TMSM 
who have socially affirmed their gender identity as for cisgender MSM. TMSM face many 
of the same sexual minority stressors that place cisgender MSM at-risk for HIV infection, 
such as homophobia and stigma.32,33 These social stressors ultimately fuel syndemics and 
appear to predispose TMSM and cisgender MSM alike to engage in high-risk sexual 
behaviours.15,34 However, TMSM face other gender-related experiences that cisgender 
MSM do not, for example, those related to social gender affirmation.3,5,23
TMSM may engage in sexual risk behaviours with cisgender MSM (e.g. condomless 
receptive anal sex) as a means of socially affirming their gender as male and their sexual 
orientation identity as a gay male.5 TMSM may engage in condomless vaginal or frontal sex. 
Among TMSM in this sample who reported last sex with a cisgender male, 21% reported 
anal sex and 79% reported vaginal sex. Vaginal/frontal sex has heterogeneous meanings for 
TMSM: vaginal/frontal sex may potentially affirm TMSM in their sexual role preference as 
a “bottom” (receptive partner) or may affirm their expression of a “transgender sexuality” 
which includes embracing trans masculine bodies and pleasures without genital surgery – a 
TMSM-specific sexuality.2 However, vaginal/frontal sex may also activate gender 
discordance given the dissonance between bioanatomical structure and gender identity as 
transgender men. Such discordance may be heightened if TMSM’s sexual partners perceive 
vaginal/frontal sex as discordant with their masculinity and therefore disaffirming of their 
social gender. Moreover, TMSM who experience genital dysphoria (i.e. unease and 
discomfort with their own genitals) may be reluctant to call attention to their bodies by 
insisting on condom use during sex. Additionally, cisgender MSM may make assumptions 
about what consistutes “safer sex” because for many gay men, condoms are only viewed as 
necessary during anal sex. These discussion points are merely speculative and data were not 
measured to test these hypotheses in the current study; more research is needed to 
understand the mechanisms through which gender affirmation processes potentiate or 
impede sexual risk for TMSM.
Social gender affirmation (i.e. presenting/living full-time in one’s identified gender) may 
give TMSM access to cisgender MSM spaces to meet sex partners where they may be 
exposed to MSM social and sexual norms, particularly for TMSM who pass in their affirmed 
masculine gender. In these spaces, non-verbal communication and cues may create in-group 
identity.35-37 TMSM may feel that they need to conform to the social-sexual expectations of 
their gay male partners, including condomless anal sex, which they perceive to be normative 
in gay male relationships.5 TMSM may also value the perceived affirmation as gay males in 
gay male spaces and forego sexual safety out of fear of rejection. Research exploring 
cisgender MSM attitudes towards sex with TMSM is needed. While qualitative work has 
been conducted to formatively examine the role of gender affirmation in sexual risk taking 
among TMSM,3,5 to the authors’ knowledge, no research has been conducted with the male 
sexual partners of TMSM. Future research exploring the knowledge, attitudes and 
behaviours of cisgender MSM who engage in sex with trans masculine people is warranted 
in order to inform the development of interventions to increase awareness, reduce stigma, 
and promote sexual safety for TMSM.
Reisner et al. Page 7
Int J STD AIDS. Author manuscript; available in PMC 2016 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A number of limitations deserve to be mentioned. First, due to the cross-sectional nature of 
the survey, results are associational and causal inferences cannot be made. Other temporal 
limitations also exist – for example, some recent measures (e.g. past six months) were used 
in the statistical prediction of lifetime outcomes that may have preceded them. Second, 
while this study gathered information from TMSM from all major regions of Massachusetts 
and utilised bimodal sampling methods to ensure a diverse community-based sample, the 
true representativeness and generalisability of this non-probability convenience sample 
cannot be determined. Third, some TMSM individuals may not conceptualise social 
transition as it was operationalised in this study – youth, in particular, may not relate to the 
rubric of “living full-time” due to endorsing non-binary gender identities. Fourth, when 
assessing sexual risk with participants’ most recent partner, we did not assess the 
relationship status of that partner or their partner’s HIV status. Thus, it is possible that the 
condomless sexual acts reported may have been in lower-risk relationships (e.g. mutually 
monogamous and sero-concordant).
Fifth, depression was assessed by asking participants whether they had been diagnosed by a 
healthcare provider in their lifetime; thus, healthcare access is a confounder. Lifetime 
diagnosis may not reflect current mental health status and may also fail to capture 
individuals suffering from depression but unable to access medical care to obtain a 
diagnosis. Finally, the health outcomes comprising the syndemic variable were examined 
among TMSM in the sample, as these conditions have each been linked to sexual risk 
behaviour among transgender individuals and have been shown to syndemically interact and 
create additive HIV risk in cisgender MSM. However, no set of health conditions are 
universally syndemic and thus it is possible that these syndemic conditions may operate 
differently among some TMSM, including those in our sample.
Despite this study’s limitations, this is one of the first studies the authors are aware of to 
demonstrate that social gender affirmation moderates the relationship between syndemic 
factors and sexual risk in TMSM. This study adds to the small, but growing body of research 
beginning to document sexual risk behaviours in TMSM – behaviours that could increase 
this community’s risk for acquiring HIV or other STIs. Findings have implications for future 
research and interventions to ensure sexual safety for TMSM. TMSM are vulnerable to 
psychosocial factors such as increased risk of experiencing syndemic dynamics modified by 
social gender affirmation – as well as biological risk (e.g. condomless anal and/or vaginal 
sex) that may potentiate HIV/STI risk. While syndemic risk should be considered for all 
MSM, including TMSM who have socially affirmed their gender, it is also vital to promote 
sexual health in trans masculine individuals who have not socially affirmed their gender, 
who may not live full-time in their identified gender, and/or who may endorse diverse 
gender presentations and expressions. Prevention programs tailored to address the unique 
psychosocial and sexual health needs of diverse TMSM are needed, including those which 
explore the dynamic processes of gender affirmation in different contexts and settings, and 
discuss managing pressures to conform to gender role expectations in sexual encounters. 
Sexual health programming for TMSM that is integrated with research and evaluation 
activities represents an important way forward given that TMSM remain under-studied and 
underserved in HIV and STI prevention and service delivery. Longitudinal projects are 
recommended to understand more about sexual risk, psychosocial factors, and gender 
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affirmation processes in TMSM over time, including examination of HIV testing behaviours, 
knowledge and acceptability of PrEP, and the extent to which testing counselors and other 
healthcare providers are discussing bio-behavioural prevention interventions with at-risk 
TMSM.
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Figure 1. 
Graphical display of study hypothesis.
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Table 6
Multivariable Logistic Regression Models: The Association of Syndemics and Unprotected Anal or Vaginal 
Sex with a Cisgender Male at Last Sex, Stratified by Social Gender Affirmation.
Social Gender Transition
(n=143)
No Social Gender Transition
(n=30)
aOR (95% CI) p-value aOR (995% CI) p-value
Syndemic Factors 1.79 (1.42, 2.25) <0.0001 0.86 (0.63, 1.19) 0.37
aOR = Adjusted Odds Ratio. 95% CI = 95% Confidence Interval. Models were adjusted for age and sampling method (online versus in-person).
Note = Socially transitioned indicates those who report living full time in their gender identity.
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